Abstract: . . .  n p a t i e n t D a y s Thrombosis Program (Established in 1996) Total OH VTE Days per 1000 Total Inpatient Days For All Diagnoses Page 5 Research in The Ottawa Hospital. Dr. Wells has accepted the position to begin August 1, immediately following his sabbatical . . .
. . .  this year 19.6 (April 05- Present) April/May 2005 Publications Wells PS, Langlois NJ, Webster MA, Jaffey J, Anderson JA. Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII? Thromb Haemost. 2005 May;93(5):842-6. Douketis JD, Julian . . .
. . .  Florack P, Touchie D, Morrow B, Gray L, O'Rourke K, Wells G, Kovacs J, Kovacs MJ. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2005 Apr 11;165(7):733-8. Carrier M, Wells PS, Rodger MA. Excluding pulmonary embolism at the bedside with  . . .
. . .  immediately following his sabbatical leave. Congrats Phil!! Kathleen Nemeth starts her new position with the Heart Institute. CONTEST! There will be a contest to name the new Thrombosis Newsletter. The winner will receive a dozen chocolate chip cookies! Please submit your entry to Nicholas Galambos ( ngalambos@ohri.ca ) by July 1 st , 2005. . . .
--1539,4,192,1837,7694